jRCT1032250682尚未招募不适用
A Prospective Study on the Effects of H12-Hemodialyzer and Low-Albumin Leakage On-Line HDF on Nutritional Status
未提供0 个研究点目标入组 12 人开始时间: 待定
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
入排标准
- 年龄范围
- 65age old over 至 No limit（—）
- 性别
- All
入选标准
- •The study subjects were dialysis patients aged 65 or older who were outpatients or hospitalized at our hospital until January 31, 2027, and whose albumin levels were 3.5 g/dL or less in the results of regular blood tests at our hospital, and whose dialysis conditions were 4 hours and a blood flow rate of 200 ml/min.
排除标准
- •Patients who need to take ACE inhibitors as antihypertensive medication.
- •Patients who are unable to make decisions.
研究者
相似试验
招募中
1 期
A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants with Advanced Solid Malignancies2024-511453-22-00Kumquat Biosciences Inc.112
招募中
2 期
A study to evaluate the safety and efficacy of the tumor-targeting human antibody-cytokine fusion protein L19TNF plus lomustine in patients with glioblastoma at first progressionGlioblastoma2022-501822-39-00Philogen S.p.A.113
招募中
1 期
A study to determine the safety and effect of antibodies against hepatitis D (the SAMBA-D study)2025-522125-36-00Region Midtjylland15
招募中
1 期
A study of the safety, absorption and effects of investigational drug ARV-102 in patients with Parkinson's disease.2024-516888-84-00Arvinas Operations Inc.44
招募中
1 期
A Phase I study to evaluate the safety and efficacy of L19IL2 in combination with ruxolitinib in patients with advanced solid tumors.2025-522243-17-00Philogen S.p.A.96